Vaccinations

A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022.Xinhua News Agency | Getty ImagesAn advisory committee to the Centers for Disease Control and…

Respiratory syncytial virus viral vaccine under research.Hailshadow | Istock | Getty ImagesGlaxoSmithKline on Wednesday said its vaccine to protect adults ages 60 and older from respiratory syncytial virus, or RSV, remained effective across…

A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022.Johanna Geron | ReutersThe U.S. Food and Drug Administration's independent panel of advisors…

Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021.Jakub Porzycki | NurPhoto | Getty ImagesNovavax has a clear message for Wall Street: The…

Respiratory syncytial virus - viral vaccine under researchHailshadow | Istock | Getty ImagesThe Food and Drug Administration's independent panel of advisors on Thursday recommended full approval of Pfizer's vaccine that protects infants…

Blood sample for respiratory syncytial virus (RSV) testJarun011 | Istock | Getty ImagesU.S. Food and Drug Administration staff on Tuesday said Pfizer's vaccine that protects infants from respiratory syncytial virus has "generally favorable"…

Pharmacist Uchita Parikh prepares a dose of the Jynneos monkeypox vaccine at a pop-up vaccination clinic opened today by the Los Angeles County Department of Public Health at the West Hollywood Library on August 3, 2022 in West Hollywood,…

Moderna's sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.Boston Globe | Getty ImagesModerna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite…

The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older.The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for…

Pharmaceutical Pfizer Inc. said that an oral drug for treating COVID-19 could be available by end of 2021.Soumyabrata Roy | NurPhoto | Getty ImagesPfizer on Tuesday reported first-quarter revenue and adjusted earnings that topped Wall…